
Bausch Health Companies
(NYSE) BHC
Bausch Health Companies Financials at a Glance
Market Cap
$1.97B
Revenue (TTM)
$10.55B
Net Income (TTM)
-$1.19B
EPS (TTM)
-$3.25
P/E Ratio
-1.63
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Price
$4.79
Volume
12,661,385
Open
$5.28
Price
$4.79
Volume
12,661,385
Open
$5.28
Previous Close
$4.76
Daily Range
$4.71 - $5.95
52-Week Range
$4.57 - $8.69
Estimated Earnings Date
Jul 29, 2026
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Price
$4.79
Volume
12,661,385
Open
$5.28
Previous Close
$4.76
Daily Range
$4.71 - $5.95
52-Week Range
$4.57 - $8.69
Estimated Earnings Date
Jul 29, 2026
BHC News


What Does Bag Holder Mean?
BHC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bausch Health Companies
Industry
Pharmaceuticals
Sector
Health CareEmployees
20,300
CEO
Thomas J. Appio
Website
www.bauschhealth.comHeadquarters
Laval, QC H7L 4A8, CA
BHC Financials
Key Financial Metrics (TTM)
Gross Margin
61.67%
Operating Margin
22.91%
Net Income Margin
-11.27%
Return on Equity
120.75%
Return on Capital
10.76%
Return on Assets
-4.86%
Earnings Yield
-61.35%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.97B
Shares Outstanding
373.48M
Volume
12.66M
Avg. Volume
1.81M
Financials (TTM)
Gross Profit
$6.51B
Operating Income
$2.42B
EBITDA
$1.97B
Operating Cash Flow
$1.42B
Capital Expenditure
-$430.39M
Free Cash Flow
$989.53M
Cash & ST Invst.
$1.30B
Total Debt
$20.80B
Bausch Health Companies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.49B
+10.5%
Gross Profit
$1.52B
+17.4%
Gross Margin
61.21%
N/A
Market Cap
$1.97B
N/A
Market Cap/Employee
$95.26K
N/A
Employees
20,700
N/A
Net Income
-$1.40B
-2326.8%
EBITDA
-$647.90M
-210.0%
Quarterly Fundamentals
Total Cash
$1.30B
+14.6%
Total Debt
$20.80B
-3.3%
Accounts Receivable
$2.19B
+5.7%
Inventory
$1.60B
-0.7%
Long Term Debt
$19.90B
-6.3%
Short Term Debt
$900.00M
+219.1%
Return on Assets
-4.86%
N/A
Return on Invested Capital
12.11%
N/A
Free Cash Flow
$83.00M
-4.6%
Operating Cash Flow
$230.00M
+9.0%





